Furthermore, Kaplan–Meier analysis established that the mean disease-specific survival time for patients with HCC who overexpressed ZEB2 in cytoplasm was 53.8 months, compared to 41.8 months for patients with HCC who normally expressed ZEB2 in cytoplasm (P = 0.026, log-rank test, Table 2, Figure 4A). This evidence concerns the gene ZEB2 and hepatocellular carcinoma.